Bristol-Myers Squibb Company operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bristol-Myers Squibb Company with three other companies in this sector in the United States: AstraZeneca PLC (2018 sales of $22.09 billion of which 100% was Pharmaceuticals), Teva Pharmaceutical Industries Limited ($18.85 billion of which 49% was North America), and Eli Lilly and Company ($24.56 billion of which 48% was Human pharmaceutical products - Endocrin).

Sales Analysis. During the year ended December of 2018, sales at Bristol-Myers Squibb Company were $22.56 billion. This is an increase of 8.6% versus 2017, when the company's sales were $20.78 billion. This was the fourth straight year of sales growth at Bristol-Myers Squibb Company.